default author photo

Xiaotian Zhang

Peking University - Key Laboratory of Carcinogenesis and Translational Research

Beijing, 100142

China

SCHOLARLY PAPERS

2

DOWNLOADS

227

TOTAL CITATIONS

2

Scholarly Papers (2)

Actions:
Email selected abstracts
1.

Safety, Efficacy and Biomarkers of Toripalimab in Patients with Recurrent or Metastatic Neuroendocrine Neoplasms: A Multiple-Center Phase Ib Trial

Number of pages: 139 Posted: 26 Nov 2019
Ming Lu, Panpan Zhang, Yanqiao Zhang, Zhongwu Li, Jifang Gong, Jie Li, Jian Li, Yan Li, Xiaotian Zhang, Zhihao Lu, Xicheng Wang, Jun Zhou, Zhi Peng, Weifeng Wang, Hui Feng, Hai Wu, Sheng Yao and Lin Shen
Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Harbin Medical University - Cancer Hospital, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Key Laboratory of Carcinogenesis and Translational Research, OrigiMed, Inc., Shanghai Junshi Biosciences Co., LTD, Shanghai Junshi Biosciences Co., LTD, Shanghai Junshi Biosciences Co., LTD and Peking University - Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing)
Downloads 181 (418,025)
Citation 2

Abstract:

Loading...

Neuroendocrine neoplasm, NET, NEC, PD-1,toripalimab

2.

Early Interdisciplinary Palliative Care in Patients with Previously Untreated Metastatic Oesophagogastric Cancer: A Phase 3 Randomised Controlled Trial

Number of pages: 68 Posted: 07 Aug 2020
Zhihao Lu, Yu Fang, Chang Liu, Xiaotian Zhang, Xiaowei Xin, Yi He, Yanshuo Cao, Xi Jiao, Tianqi Sun, Ying Pang, Yanli Wang, Jun Zhou, Changsong Qi, Jifang Gong, Xicheng Wang, Jian Li, Lili Tang and Lin Shen
Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Department of Clinical Nutrition, Peking University - Department of Gastrointestinal Oncology, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Department of Clinical Nutrition, Peking University - Department of Psycho-Oncology, Peking University - Department of Gastrointestinal Oncology, Peking University - Department of Gastrointestinal Oncology, Precision Scientific (Beijing) Co., Ltd., Peking University - Department of Psycho-Oncology, Peking University - Department of Clinical Nutrition, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Department of Gastrointestinal Oncology, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Department of Psycho-Oncology and Peking University - Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing)
Downloads 46 (1,109,210)

Abstract:

Loading...

Early interdisciplinary palliative care; oesophagogastric cancer; survival; randomised controlled trial